Logo 24G
0 0,00

Artificial intelligence

Over the past few years, we have experienced an exponential increase in data creation. From when our smartphone tells us how many steps we take, to count the times we get on public transport, to how many megabytes we spend on our mobile data rate.


Big data

Just as this data is generated from our daily lives, it the same happens in the clinical environment: the number of times we visit the emergency room, the occasions we suffer hospital admissions, the number of drugs prescribed or the X-rays taken throughout our lives, among others.


Artificial Intelligence

The immense amount of data is far beyond human analytical capacity. It requires technology that is capable of storing, processing and protecting this valuable data. Therefore, it is not only the help of computers necessary but also artificial intelligence and algorithms. And thanks precisely to these and other tools (deep learning, machine learning) in recent years are making many discoveries, in addition to predicting future scenarios in terms of epidemiology, as is the case of urogenital cancer.


Deep learning

Another example of these new tools, this time deep learning: Case in which the machine learns to recognize a series of patterns, in this example, has been the analysis of ophthalmological fundus. Today we know the relationship of the ocular fundus and its relationship with heart disease. What we were not able to predict and with such a high level of accuracy was the risk, as well as other parameters.  The machine analyzed more than 200,000 patients and has been able to identify not only risk patterns but also the sex of the participating population, through the thickness of the eye’s veins alone—something that human capacity has not achieved, impossible to date.


AI and pharmacogenetics

Also, significant advances are forthcoming in the field of pharmacogenetics. Can you imagine that we will not have to test new drugs in human and non-human animal populations? Various teams are already carrying out this type of research. Through the use of artificial intelligence and massive data, the possible impact that multiple drugs can have on the population is already in study.


AI here to stay

Artificial intelligence arrived a few decades ago to stay, and not in vain. We will see in the future how all this massive amount of mass data will impact the world’s population. For the moment, the foundations of what should be a universal ethical framework are already ongoing. And that ethical framework must address universal principles such as transparency, fairness, non-maleficence, accountability and privacy.

Written by Manuel de la Mata


The influence of genetics on celiac disease

What is celiac disease? Celiac disease is a chronic autoimmune disease affecting the digestive system. It is characterized by an intolerance to gluten, a protein found in wheat, barley, rye, and crossbreeds of these grains. When a person with celiac disease consumes...

read more

April 25th: World DNA Day

April 25th: World DNA DayThe discovery of DNA is one of the most significant milestones in the history of science and, to this day, remains the basis for many medical discoveries and advances. April 25th is the day on which two main passages in genetics and, by...

read more

Is pancreatic cancer hereditary?

The pancreas is a glandular organ behind the stomach and in front of the spine. It produces gastric juices, enzymes that break down food, and several hormones that help control blood glucose levels. A tumor starts developing when there’s an abnormal growth of the...

read more

Lynch syndrome and genetic inheritance

Lynch syndrome is a genetic disorder that increases the likelihood of developing certain types of cancer, especially colorectal cancer. For this reason, Lynch disease has always been referred to as hereditary nonpolyposis colorectal cancer [1]. If you want to know...

read more

Is neuroblastoma hereditary?

There are different types of cancerous tumors, depending on several aspects: where they develop, the causes, the tissue they affect, etc. In this case, we will talk about neuroblastoma, a cancer in immature nerve cells found in different body parts.  It's a malignant...

read more

Colorectal cancer and genetics

Genetics is an essential factor in the development of colorectal cancer. A large number of genes may influence each person's predisposition to develop this disease at some point in his or their life. In addition, these genes may also be involved in developing other...

read more

Myasthenia gravis and genetics

Myasthenia gravis is a disease that belongs to the group of neuromuscular diseases, described as disorders that affect the connection between muscles and nerves, resulting in muscle weakness, fatigue, and a range of other symptoms. Millions of people worldwide suffer...

read more
    Your cart is empty
      Calculate Shipping
      Apply Coupon